“…Variable positivity of NMC tumors has been noted for markers including CD99, FLI1, CD45 RO, NSE, CD34 (50%), vimentin, and focally, p16, CD56, CD138, TTF1, S-100, CD117, and PLAP. 6,11,[15][16][17][18][19][20][21] The antibody created to diagnose NMC with IHC is a rabbit monoclonal raised against amino acids 450 to 700 of the human NUT protein. 13 The IHC staining pattern demonstrates a diffuse (>90%), speckled nuclear staining in the malignant tumor cells.…”